Company news

GNI Group Ltd. news in 2026

GNI Group Ltd.'s news releases, calls and decks from 2026, newest first.

View company

From the Growth Market to TOPIX: GNI Group Newly Selected in the First Periodic Review Following TOPIX Reform

October 7, 2026

Promotion of Proprietary Brand Business in the Medtech Segment

September 2, 2026

Notice Regarding Change in Major Shareholder

August 23, 2026

Q2 FY2026 Financial Results Corporate Presentation

August 18, 2026

Consolidated Financial Results for Q2 FY2026 (IFRS)

August 14, 2026

Notice Concerning the Completion of the Acquisition of All Shares of AYUMI Pharmaceutical Holdings KK (Conversion into a Wholly-Owned Subsidiary)

July 1, 2026

Notice Regarding the Execution of a Loan Agreement Containing Financial Covenants

June 26, 2026

Notice Concerning Filing of Form S-3 Registration Statement by Gyre Therapeutics

June 23, 2026

GNI Group to Acquire Ayumi Pharmaceutical Holdings, Expanding Its Position as a Global Biopharmaceutical Company

June 7, 2026

Transformational Acquisition of Ayumi Pharmaceutical Holdings

June 5, 2026

Decks in 2026